As shown by immunoblot analysis, breast cancer cells treated with α-mangostin result in decrease of anti-apoptotic Bcl-2 and a concomitant increase of pro-apoptotic Bax proteins, thereby caused a significant increase in the Bax/Bcl-2 ratio that favors apoptosis. This evidence concerns the gene BCL2 and breast carcinoma.